Ani Pharmaceuticals, Inc.

MN · United States · Reporting entity ID 100000971883

Total reported 2019–2025

$7.24M

#589 of 2,960 reporting companies — 0% of all reported industry payments

$4.93M in general payments across 76,640 records, plus $2.32M in research funding across 185 records.

How it breaks down

General payments $4,926,080

Research funding $2,316,741

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.